Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nesiritide in pulmonary hypertension.

Damian C Kurian1, Ira J Wagner, Marc Klapholz

  • 1Saint Vincent Catholic Medical Centers, New York, NY 10011, USA.

Chest
|July 14, 2004
PubMed
Summary

Continuous nesiritide infusion effectively treated severe pulmonary hypertension in a patient with rheumatic mitral valve disease. This therapy improved pulmonary vascular resistance and renal function when traditional treatments failed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Successful Percutaneous Coronary Stenting in End-Stage Liver Disease Patients Awaiting Liver Transplantation.

Cureus·2025
Same author

Migration of Hepatocellular Carcinoma Into the Right Atrium.

JACC. Case reports·2025
Same author

Matched Cohort Study of Convalescent COVID-19 Plasma Treatment in Severely or Life Threateningly Ill COVID-19 Patients.

Open forum infectious diseases·2021
Same author

Trends in Cardiac Tamponade Among Recipients of Permanent Pacemakers in the United States: From 2008 to 2012.

JACC. Clinical electrophysiology·2018
Same author

A Phase 2a dose-escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS-986231 in hospitalized patients with heart failure with reduced ejection fraction.

European journal of heart failure·2017
Same author

Chordae Tendineae Rupture in the United States: Trends of Outcomes, Costs and Surgical Interventions.

The heart surgery forum·2017

Area of Science:

  • Cardiology
  • Pulmonology
  • Nephrology

Background:

  • Rheumatic mitral valve disease can lead to severe symptomatic pulmonary hypertension.
  • Pulmonary hypertension refractory to conventional therapies presents a significant clinical challenge.

Observation:

  • A patient with severe pulmonary hypertension secondary to rheumatic mitral valve disease did not respond to standard treatments, including prostacyclin.
  • Continuous intravenous nesiritide infusion was initiated as a salvage therapy.

Findings:

  • Nesiritide infusion led to substantial and lasting reductions in pulmonary vascular resistance.
  • The patient experienced improved renal function and maintained fluid balance (euvolemia) during treatment.

Implications:

  • Continuous nesiritide infusion may represent a viable therapeutic option for refractory pulmonary hypertension in the context of rheumatic heart disease.
  • This case highlights the potential benefits of nesiritide in managing complex cardiovascular and renal comorbidities.

Related Experiment Videos